HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258,707 | +11.1% | 2,888 | +5.6% | 0.01% | +18.2% |
| Q2 2023 | $232,858 | +2.9% | 2,735 | 0.0% | 0.01% | -8.3% |
| Q1 2023 | $226,321 | -10.1% | 2,735 | -14.6% | 0.01% | +9.1% |
| Q4 2022 | $251,837 | +11.0% | 3,202 | +4.5% | 0.01% | 0.0% |
| Q3 2022 | $226,828 | +13.6% | 3,064 | 0.0% | 0.01% | +22.2% |
| Q2 2022 | $199,712 | -3.6% | 3,064 | -6.5% | 0.01% | +28.6% |
| Q1 2022 | $207,109 | -81.7% | 3,276 | -84.6% | 0.01% | -53.3% |
| Q4 2021 | $1,130,866 | -25.4% | 21,321 | -0.8% | 0.02% | -31.8% |
| Q3 2021 | $1,516,838 | +1.4% | 21,488 | -4.3% | 0.02% | +4.8% |
| Q2 2021 | $1,496,401 | +11.8% | 22,455 | +86.2% | 0.02% | +5.0% |
| Q1 2021 | $1,339,003 | -3.7% | 12,062 | +3.0% | 0.02% | -4.8% |
| Q4 2020 | $1,390,681 | +33.0% | 11,711 | -2.3% | 0.02% | +16.7% |
| Q3 2020 | $1,045,430 | -6.6% | 11,982 | -4.2% | 0.02% | -10.0% |
| Q2 2020 | $1,119,679 | -58.8% | 12,502 | -54.2% | 0.02% | -65.5% |
| Q1 2020 | $2,718,426 | -17.5% | 27,277 | -4.9% | 0.06% | +5.5% |
| Q4 2019 | $3,295,332 | -10.1% | 28,680 | -1.3% | 0.06% | -11.3% |
| Q3 2019 | $3,664,998 | +1.8% | 29,055 | -2.9% | 0.06% | +1.6% |
| Q2 2019 | $3,601,175 | +37.8% | 29,925 | +0.2% | 0.06% | +29.8% |
| Q1 2019 | $2,613,028 | -13.8% | 29,870 | -1.4% | 0.05% | -23.0% |
| Q4 2018 | $3,030,615 | -11.9% | 30,291 | +0.9% | 0.06% | 0.0% |
| Q3 2018 | $3,438,775 | -99.9% | 30,012 | -3.4% | 0.06% | +35.6% |
| Q2 2018 | $2,785,998,000 | +129.1% | 31,066 | +86.9% | 0.04% | +164.7% |
| Q1 2018 | $1,216,066,000 | +122117.7% | 16,622 | -2.9% | 0.02% | +30.8% |
| Q4 2017 | $995,000 | -36.5% | 17,126 | -51.0% | 0.01% | +30.0% |
| Q3 2017 | $1,568,000 | +13.6% | 34,950 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $1,380,000 | -2.7% | 34,950 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $1,418,000 | +0.9% | 34,950 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $1,405,000 | +1.6% | 34,950 | -8.5% | 0.01% | 0.0% |
| Q3 2016 | $1,383,000 | +23.6% | 38,204 | -1.0% | 0.01% | +25.0% |
| Q2 2016 | $1,119,000 | -17.1% | 38,586 | 0.0% | 0.01% | -20.0% |
| Q1 2016 | $1,350,000 | +15.8% | 38,586 | +6.7% | 0.01% | +11.1% |
| Q4 2015 | $1,166,000 | +0.9% | 36,167 | +1.1% | 0.01% | +12.5% |
| Q3 2015 | $1,156,000 | -23.6% | 35,756 | -2.2% | 0.01% | -27.3% |
| Q2 2015 | $1,513,000 | -18.4% | 36,574 | -11.4% | 0.01% | -21.4% |
| Q1 2015 | $1,854,000 | +20.0% | 41,284 | 0.0% | 0.01% | +27.3% |
| Q4 2014 | $1,545,000 | +9.0% | 41,284 | +1.6% | 0.01% | +10.0% |
| Q3 2014 | $1,418,000 | -3.8% | 40,619 | -2.8% | 0.01% | 0.0% |
| Q2 2014 | $1,474,000 | +8.2% | 41,780 | 0.0% | 0.01% | +11.1% |
| Q1 2014 | $1,362,000 | -23.1% | 41,780 | -0.7% | 0.01% | -25.0% |
| Q4 2013 | $1,772,000 | +6.2% | 42,056 | +0.6% | 0.01% | -7.7% |
| Q3 2013 | $1,668,000 | -3.5% | 41,819 | 0.0% | 0.01% | -7.1% |
| Q2 2013 | $1,729,000 | – | 41,819 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |